Evidence map›Paper›PMID 41949422›Full record

ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Application of Novel Thrombosis Scale in Fracture Related Lower Extremity Deep Venous Thrombosis.

Zhi-Chang Pan, Tian-Yi Lu, Xin Wang, Guang-Feng Zheng, Qiang Zhang, Shu-Ming Shi, Hua-Fa Que, Jian-Jie Rong

Abstract read
In one paragraph

Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhi-Chang PanDepartment of Vascular Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, China.
Tian-Yi LuDepartment of Vascular Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, China.
Xin WangDepartment of Vascular Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, China.
Guang-Feng ZhengDepartment of Vascular Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, China.
Qiang ZhangDepartment of Vascular Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, China.
Shu-Ming ShiDepartment of Vascular Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, China.
Hua-Fa QueDepartment of Traditional Chinese Surgery, Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Jian-Jie RongDepartment of Vascular Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, Jiangsu Province, China.ORCID 0000-0002-1201-8916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundLower limb fractures with peripheral deep venous thrombosis (DVT) are common, yet unified stratified treatment standards are lacking. Quantifying thrombus burden guides decisions like inferior vena cava (IVC) filter implantation or anticoagulation. Existing scoring systems rarely integrate peripheral vein anatomy and imaging features, limiting clinical utility.ObjectiveTo develop a dual-dimensional scoring scale for thrombus burden quantification and validate its value in guiding stratified treatment.MethodsA retrospective study of 68 fracture-related DVT patients (Suzhou TCM Hospital, Nov 2022-Nov 2023) was conducted. A 0-25 point scale integrating 7 peripheral veins and muscular venous plexus features was designed. Receiver operating characteristic (ROC) analysis identified the optimal IVC filter cutoff; patients were split into filter group (≥4 points, n = 21, filter + anticoagulation) and anticoagulation group (<4 points, n = 47, single anticoagulation). 1:2 PSM eliminated baseline confounding; adverse events, scores and coagulation indices were compared.ResultsNo adverse events or filter-related complications occurred. Both groups had significant post-treatment score and D-dimer reductions (all

Indexed as

Fractures, BoneLower ExtremityVenous ThrombosisAdultAgedFemaleHumansMaleMiddle AgedRetrospective StudiesVena Cava Filtersanticoagulation therapycoagulation indicesdual-dimensional scoring scaleinferior vena cava filterlower limb fractureperipheral deep venous thrombosisthrombus burden

Identifiers

PMID41949422
PMCPMC13065273

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.